Researcher, the discovery platform for academics and scientists, and Pharmaceutical Media Inc, (PMI), a leading sales firm specializing in representing medical publishers and professional medical organizations, today announce a partnership that will enable PMI to add Researcher’s innovative advertising products to the suite of channels it offers to businesses in the life sciences and publishing sectors.
Researcher is delighted to announce a new collaboration with Enago, https://www.enago.com/org/researcher/.
If you’re a scientist, researcher, doctor, engineer, economist, journalist working on responses to COVID-19 - or perhaps you’re just interested - we want to make sure that staying up to the minute with the latest research and papers about COVID-19 is as easy as possible.
We want to make sure you never miss important papers that could change the course of your work and accelerate a breakthrough that could change lives - so we’re creating a series of resources to help you:
- We created The COVID-19 International Research Collaboration (CIRC). CIRC aggregates the papers that have the most engagement from the highest quality users on Researcher. The papers are split into the following themes: Vaccine, Drugs, Treatment, Drug Pathways, Sequencing, Economic Impact, Social Impact and Epidemiology.
COVID-19 cases currently stand at over 445,000 worldwide. Now more than ever, scientists, researchers and publishers are working together to accelerate and distribute research that can contribute to the cessation of this pandemic.
Since mid-January 2020, there has been a rapid increase in the amount of papers relating to coronaviruses as a collective, and COVID-19. As of 17/03/2020 there have been a total of 1,882 COVID-19 related paper abstracts published across 530 different journals on Researcher.
To recognise the International Day of Women and Girls in Science, we are celebrating the most prominent women scientists and their research. There are a significant number of women in science making a major impact in their respective fields, and although this number is increasing, they are still significantly underrepresented in STEM.
